Observational analysis shows similar abstinence rates with contingency management in patients with substance use disorders, suggesting broader access is essential.
CPPs are expanding access to CM for abstinence and adherence to injectable medications for SUD, with similar rates of abstinence and adherence seen in the current literature. Continued expansion of the CPP provision of CM in various outpatient settings would further expand access to these evidence-based treatments for patients with SUD.
No takes yet. Share an insight, caveat, or question.
Salsman et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: